APA (7th ed.) Citation

JS, T., LL, S., M, I., NS, A., CF, M., AJ, O., . . . AB, E. (2025). Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: Results from an open-label phase 1/2 dose escalation study. EBioMedicine, 121, 105980. https://doi.org/10.1016/j.ebiom.2025.105980

Chicago Style (17th ed.) Citation

JS, Thomas, et al. "Safety and Efficacy of Intratumourally Administered INT230-6 in Adult Patients with Advanced Solid Tumours: Results from an Open-label Phase 1/2 Dose Escalation Study." EBioMedicine 121 (2025): 105980. https://doi.org/10.1016/j.ebiom.2025.105980.

MLA (9th ed.) Citation

JS, Thomas, et al. "Safety and Efficacy of Intratumourally Administered INT230-6 in Adult Patients with Advanced Solid Tumours: Results from an Open-label Phase 1/2 Dose Escalation Study." EBioMedicine, vol. 121, 2025, p. 105980, https://doi.org/10.1016/j.ebiom.2025.105980.